List of works - Suzanne J. Hodgkinson

A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease

scientific article published on 5 February 2014

A new era in the treatment of multiple sclerosis

scientific article (publication date: 3 August 2015)

Alloantigen specific T regulatory cells in transplant tolerance.

scientific article published on 29 January 2009

Anti-neuronal antibodies associated with a first episode of mania

scientific article published on 30 May 2014

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

scientific article

CD4(+), CD25(+) T cells as regulators of alloimmune responses

scientific article published on 01 February 2001

CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

scientific article published on 30 September 2008

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

scientific article published on April 2015

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.

scientific article published on 16 October 2013

Decreasing presentations of seizures to emergency departments in a large Australian population

scientific article published on 22 September 2009

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells ⬇️

scientific article published on August 11, 2011

Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.

scientific article published on 26 November 2009

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

scientific article published on January 1996

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration

scientific article published on 28 January 2008

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

scientific article published on 3 November 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation

scientific article published on 3 November 2006

IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity

scientific article published on 6 February 2012

Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.

scientific article published on August 2013

Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells

scientific article

Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

scientific article published on 9 May 2014

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

scientific article

Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis

scientific article

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

scientific article published in September 2001

Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection

scientific article published in May 2005

Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09).

scientific article published on 10 May 2013

Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.

scientific article published on 8 June 2012

Relationship between stress and relapse in multiple sclerosis: Part I. Important features

scientific article

Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships.

scientific article

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

scientific article published on 01 August 1994

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

scientific article published on 19 January 2016

Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?

scientific article

Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures

scientific article published on 09 October 2007

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

scientific article published on 17 January 2015

The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

scientific article published on May 2015

The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance

scientific article published on 21 February 2006

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

scientific article published on 30 June 2014

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

scientific article

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

scientific article published on 30 June 2014

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens

scientific article published in April 2007

Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes

scientific article published on 01 May 1994

Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration

scientific article published on 01 March 2007

Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.

scientific article published on 15 December 2014

Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation.

scientific article published on December 1996

List of works by Suzanne J. Hodgkinson

A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease

A new era in the treatment of multiple sclerosis

Alloantigen specific T regulatory cells in transplant tolerance.

Anti-neuronal antibodies associated with a first episode of mania

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

CD4(+), CD25(+) T cells as regulators of alloimmune responses

CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.

Decreasing presentations of seizures to emergency departments in a large Australian population

Defining secondary progressive multiple sclerosis

Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells ⬇️

Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance.

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation

IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity

Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.

Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells

Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection

Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09).

Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.

Relationship between stress and relapse in multiple sclerosis: Part I. Important features

Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships.

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?

Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolo

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association o

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens

Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes

Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration

Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.

Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation.